Eliem Therapeutics, Inc.
- Sector
- Biotech
- Headquarters
- DE
- Federal grants
- None on recordNo awards found in SBIR/STTR, NIH, NSF or DoD records.
- Private capital raised
- None on recordNo Form D filings on SEC EDGAR. Some raises are not filed.
- Federal contracts
- None on recordNo federal contract awards found.
- Granted patents
- 3
- 1 pending · first 2021
Capital timeline
No federal awards or Form D filings are on record for this company.
Many early companies raise without filing a Form D, or have not yet won a federal award. New records appear here as the sources update.
Checked: SEC EDGAR Form D through Oct 23, 2026; SBIR and STTR awards through Oct 21, 2026; USAspending contract awards
Founder? Add funding contextFounders and team
Researcher links verified by same-company patents and grants- Andrew LevinResearcherExecutive Officer, DirectorLinked by 3 patents
- Adam RosenbergDirectorNamed in SEC Form D filings
- Aoife BrennanExecutive Officer, DirectorNamed in SEC Form D filings
- David-Alexandre GrosDirectorNamed in SEC Form D filings
- Erin LavelleExecutive OfficerNamed in SEC Form D filings
- Harald StockDirectorNamed in SEC Form D filings
Show all 15 people
- James BucherExecutive OfficerNamed in SEC Form D filings
- Judith DunnDirectorNamed in SEC Form D filings
- Julio VegaExecutive OfficerNamed in SEC Form D filings
- Leone PattersonDirectorNamed in SEC Form D filings
- Liam RatcliffeDirectorNamed in SEC Form D filings
- Robert AzelbyExecutive Officer, DirectorNamed in SEC Form D filings
- Simon TateDirectorNamed in SEC Form D filings
- Stephen ThomasDirectorNamed in SEC Form D filings
- Valerie MorissetExecutive OfficerNamed in SEC Form D filings
What it has protected
USPTO · 3 granted of 4- PendingMethods Of Treating Female Health Conditions Related To Sex HormonesUSPTOApplication 18008505
- GrantedCompositions That Preferentially Potentiate Subtypes Of Gabaa Receptors And Methods Of Use ThereofUSPTOUS 11,571,432
- GrantedN-acylethanolamide Derivatives And Uses ThereofUSPTOUS 11,547,681
Show all 4 patent records
- Methods Of Treating Female Health Conditions Related To Sex HormonesJul 6, 2023 · Application 18008505Pending
- Compositions That Preferentially Potentiate Subtypes Of Gabaa Receptors And Methods Of Use ThereofFeb 7, 2023 · US 11,571,432Granted
- N-acylethanolamide Derivatives And Uses ThereofJan 10, 2023 · US 11,547,681Granted
- N-acylethanolamide Derivatives And Uses ThereofMar 2, 2021 · US 10,933,037Granted
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .